Free Design Audit Available - Click Here for Details

Magstim wins FDA nod for latest transcranial magnetic stim tech

Magstim announced today that it received FDA clearance for its Horizon 3.0 transcranial magnetic stimulation (TMS) system with StimGuide Pro.

The latest platform builds on the previous H 3.0 system for treating patients with depressive or obsessive-compulsive conditions.

Horizon 3.0 with StimGuide Pro is the first integrated TMS system with navigation, Magstim said in a news release. It includes new advanced camera technology and software designed to allow for precise treatment targeting.

The system centralizes all patient treatments and technology on one screen to reduce complexity as well. It also has a Bluetooth anatomical pointer for mapping and treating patients.

Sign up for Blog Updates